Skip to Main Navigation
Skip to Page Content

Testing Status of Retroviral vectors M910057



Known Uses

Experimental treatment for immune deficiency disorders

Short-Term Toxicity

  • 1 week (Intraperitoneal Injection)  (C91009B)  Completed 
    • Rats: F344/N
  • 2 weeks (Whole Body Exposure)  (C91009C)  Completed 
    • Rats: F344/N; Mice: B6C3F1; Mice: P53 +/- (C57BL/6)
  • 3 days (Intravenous)  (C91009D)  Completed 
    • Mice: B6C3F1; Mice: P53 +/- (C57BL/6)
  • 2 weeks (Intraperitoneal Injection)  (C91009)  Completed 
    • Mice: B6C3F1